Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Item
http://www.wikidata.org/entity/Q38788274
Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Emerging Diagnostic and Therapeutic Strategies for Tauopathies.Reply to: MRI measures of brainstem in parkinsonian syndromes: Where we stand and where we need to go.What would Dr. James Parkinson think today? The 21st Annual Congress of the International Parkinson's disease and movement disorders society.Structural and Functional Brain Mapping Correlates of Impaired Eye Movement Control in Parkinsonian Syndromes: A Systems-Based Concept.Is it Useful to Classify Progressive Supranuclear Palsy and Corticobasal Degeneration as Different Disorders? No
P2860

Which ante mortem clinical features predict progressive supranuclear palsy pathology?

Item
http://www.wikidata.org/entity/Q38788274
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
@en
type
label
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
@en
prefLabel
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932